Article Data

  • Views 2117
  • Dowloads 137

Original Research

Open Access

Characteristics and prognosis of ovarian metastatic tumors: review of a single-institution experience

  • V. Ulker1,*,
  • C. Numanoglu1
  • V. Alpay2
  • O. Akbayir1
  • I. Polat2
  • A. Gedikbasi2
  • A. Akca2

1Department of Obstetrics and Gynecology, Oncology Unit, Bakirkoy Woman and Children Training and Research Hospital, Istanbul

2Department of Obstetrics and Gynecology, Bakirkoy Woman and Children Training and Research Hospital, Istanbul (Turkey).

DOI: 10.12892/ejgo340114 Vol.34,Issue 1,January 2013 pp.75-78

Published: 10 January 2013

*Corresponding Author(s): V. Ulker E-mail: drvolkanulker@yahoo.com

Abstract

Background: To evaluate the clinico-pathological characteristics and role of surgery in patients with ovarian metastasis. Materials and Methods: Clinical data from 51 patients with pathologically confirmed ovarian metastasis were reviewed. Results: Ovarian metastasis accounted for 14% of all malignant ovarian neoplasms (51/364). Of the 51 metastatic ovarian tumor cases, 24 originated from gynecologic malignancies, while 27 originated from non-gynecologic malignancies. Optimal cytoreduction was performed in 88% and 37% of patients with metastases of gynecologic and non-gynecologic origin, respectively. Patients with ovarian metastasis had a two-year survival rate in 82% of the gynecologic group and 70% of the non-gynecologic group (p = 0.35). The five-year survival rate of patients with non-gynecologic tumor origin (29%) was significantly worse (p = 0.04) than the survival rates of those with tumors of gynecologic origin (61%). In the non-gynecologic group, the five-year survival rates were significantly different between patients who were performed optimal cytoreductive surgery vs those without this procedure (42% and 20%, respectively; p = 0.04). Conclusion: Although complete surgical resection is not achievable in approximately two-thirds of patients with metastases of non-gynecological origin, optimal tumor cytoreduction appears to improve survival, which is statistically significant in all patients with ovarian metastatic tumors.

Keywords

Ovarian metastasis; Cytoreductive surgery; Krukenberg tumor.

Cite and Share

V. Ulker,C. Numanoglu, V. Alpay,O. Akbayir,I. Polat,A. Gedikbasi, A. Akca. Characteristics and prognosis of ovarian metastatic tumors: review of a single-institution experience. European Journal of Gynaecological Oncology. 2013. 34(1);75-78.

References

[1] Yada-Hashimoto N., Yamamoto T., Kamiura S., Seino H., Ohira H., Sawai K. et al.: “Metastatic ovarian tumors: a review of 64 cases”. Gynecol. Oncol., 2003, 89, 314.

[2] Ulbright T.M., Roth L.M., Stehman F.B.: “Secondary ovarian neoplasia: a clinicopathologic study of 35 cases”. Cancer, 1984, 53, 1164.

[3] Santesson L., Kottmeier H.L.: “General classification of ovarian tumours”. In: Gentil F., Junqueira A.C. (eds.). Ovarian cancer. UICC monograph series, vol. 11. Berlin’ Springer-Verlag, 1968, 1.

[4] Petru E., Pickel H., Heydarfadai M., Lahousen M., Haas J., Schaider H. et al.: “Nongenital cancers metastatic to the ovary”. Gynecol. Oncol., 1992, 44, 83.

[5] Ayhan A., Guvenal T., Salman M.C., Ozyuncu O., Sakinci M., Basaran M.: “The role of cytoreductive surgery in nongenital cancers metastatic to the ovaries”. Gynecol. Oncol., 2005, 98, 235.

[6] Kim W.Y., Kim T.J., Kim S.E., Lee J.W., Lee J.H., Kim B.G., Bae D.S.: “The role of cytoreductive surgery for non-genital tract metastatic tumors to the ovaries”. Eur. J. Obstet. Gynecol. Reprod. Biol., 2010, 149, 97.

[7] Young R.H., Scully R.E.: “Differential diagnosis of ovarian tumors based primarily on their patterns and cell types”. Semin. Diagn. Pathol., 2001, 18, 161.

[8] Webb M.J., Decker D.G., Mussey E.: “Cancer metastatic to the ovary: factors influencing survival”. Obstet. Gynecol., 1975, 45, 391.

[9] Fujiwara K., Ohishi Y., Koike H., Sawada S., Moriya T., Kohno I.: “Clinical implications of metastases to the ovary”. Gynecol. Oncol., 1995, 59, 124.

[10] Miller B.E., Pittman B., Wan J.Y., Fleming M.: “Colon cancer with metastasis to the ovary at time of initial diagnosis”. Gynecol. Oncol., 1997, 66, 368.

[11] Lee S.J., Bae J.H., Lee A.W., Tong S.Y., Park Y.G., Park S.J.: “Clinical characteristics of metastatic tumors to the ovaries”. J. Korean Med. Sci., 2009, 24, 114.

[12] Woodruff J.D., Novak E.R.: “The Krukenberg tumor: study of 48 cases from the ovarian tumor registry”. Obstet. Gynecol., 1960, 15, 351.

[13] Yong-Jung Song B.G.K., Sang-Young R.: “Clinicopathologic characteristics of 42 cases of Krukenberg tumor of the ovary. Korean J. Obstet. Gynecol., 2001, 44, 2243.

[14] Cheong J.H., Hyung W.J., Chen J., Kim J., Choi S.H., Noh S.H.: “Surgical management and outcome of metachronous Krukenberg tumors from gastric cancer”. J. Surg. Oncol., 2004, 87, 39.

[15] Hunter J.A., Ryan J.A., Schultz P.: “En bloc resection of colon cancer adherent to other organs”. Am. J. Surg., 1987, 154, 67.

Submission Turnaround Time

Top